U.S. Capital Wealth Advisors LLC Buys 400 Shares of CVS Health Corporation $CVS

U.S. Capital Wealth Advisors LLC raised its stake in shares of CVS Health Corporation (NYSE:CVS) by 3.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 13,155 shares of the pharmacy operator’s stock after buying an additional 400 shares during the quarter. U.S. Capital Wealth Advisors LLC’s holdings in CVS Health were worth $907,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of CVS. Bell Investment Advisors Inc raised its holdings in CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after buying an additional 248 shares during the last quarter. Roxbury Financial LLC increased its position in shares of CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 202 shares in the last quarter. Saudi Central Bank purchased a new position in CVS Health in the 1st quarter worth approximately $34,000. Livelsberger Financial Advisory bought a new position in CVS Health in the 2nd quarter valued at approximately $35,000. Finally, Costello Asset Management INC boosted its stake in CVS Health by 281.3% during the 1st quarter. Costello Asset Management INC now owns 572 shares of the pharmacy operator’s stock valued at $39,000 after purchasing an additional 422 shares during the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Stock Down 0.2%

CVS opened at $76.36 on Thursday. The firm’s 50 day simple moving average is $68.63 and its two-hundred day simple moving average is $66.84. The company has a market capitalization of $96.85 billion, a PE ratio of 21.33, a PEG ratio of 0.84 and a beta of 0.62. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $77.34. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. During the same quarter in the previous year, the firm posted $1.83 EPS. The company’s revenue for the quarter was up 8.4% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, equities analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be paid a $0.665 dividend. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. CVS Health’s dividend payout ratio (DPR) is 74.30%.

Wall Street Analysts Forecast Growth

CVS has been the topic of several recent analyst reports. Morgan Stanley increased their price objective on CVS Health from $80.00 to $82.00 and gave the company an “overweight” rating in a research report on Friday, August 1st. Wall Street Zen raised shares of CVS Health from a “hold” rating to a “buy” rating in a report on Sunday. Cowen reissued a “buy” rating on shares of CVS Health in a report on Monday, August 4th. Sanford C. Bernstein raised their target price on shares of CVS Health from $72.00 to $77.00 and gave the stock a “market perform” rating in a report on Friday, September 5th. Finally, Bernstein Bank decreased their target price on shares of CVS Health from $78.00 to $72.00 and set a “market perform” rating for the company in a research note on Wednesday, July 16th. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and an average price target of $78.25.

Insider Activity

In related news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the sale, the director directly owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. This represents a 25.29% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.22% of the company’s stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.